State of Biomedical Innovation Conference
On July 16, the Engelberg Center for Health Care Reform at Brookings hosted the second annual State of Biomedical Innovation conference. The goal of this conference was to assess U.S. biomedical innovation and discuss policy solutions that ensure the nation remains a world leader. This year, the conference featured an update to last year’s discussion of the drivers of innovation and how best to track them through use of comprehensive metrics. In addition, the conference specifically focused on novel sources and applications of big data in innovation, with senior-level thought leaders from government, academia, industry, patient advocacy, and clinical care present to share their views and recommendations.
General Manager, Client Services & Strategic Initiatives - PatientsLikeMe
Chief Executive Officer - TransCelerate BioPharma Inc.
Chief Medical Scientist, Care Delivery Systems - Watson Research Center, IBM
President and Research Director - Translational Genomics Research Institute
Senior Vice President - IMS Health
Director, Tufts Center for the Study of Drug Development, and Professor - Tufts University School of Medicine
Partner - Deerfield Management
Founder - InnoThink Center for Research in Biomedical Innovation
“The 21st century has revalued these small geographies. That’s what the 21st century demands,” Katz said, noting that these days, “[w]e aren’t innovating in isolated business parks” in the suburbs.
"Instead of stopping trade, modernize the trade agreements, but also provide safety nets for workers. Because these things are going to keep happening, not only because of trade but because of modernization."